🚨 In our meta-analysis in @EUplatinum, longer RCT follow-up now provides HIGH certainty in a prostate cancer mortality benefit from screening
https://t.co/1uVQ4uVZdG
Earlier syntheses found uncertain evidence of little or no PCSM benefit
Some thoughts/highlights below 👇
Dr. Washington an emerging leader in prostate cancer research has received the 2024 PCF Young Investigator Award! This prestigious recognition highlights his innovative research into the social factors influencing prostate cancer outcomes. @SamWashUro
https://t.co/8f7WhJykfr
PEACE-3 trial results show the benefits of adding radium-223 to enzalutamide in mCRPC and underscore the importance of bone-protecting agents.
Dr. Fred Saad discusses how this combination therapy can improve outcomes: https://t.co/IVJuLZnNrz
@urotoday
Congratulations to Dr Maranchie @UPMCUrology @SWIUorg member on becoming 1st American female president of @nsaua following Trail Blazers Canadian section présidents Drs Houle & Franc-Guimond. A great year ahead. All the best to Dr Maranchie & our section
See LithoVue™ Elite in action and learn how @DrBenChew & @NaeemBhojani7 use the real-time intrarenal pressure data to make clinical decisions in the OR. https://t.co/zYwg8MwQkg
#StoneSmart#LithoVueElite
Congrats Dr. Fred Saad on receiving the prestigious CUA Lifetime Achievement award at the President's Banquet. Thank you for your commitment to the CUA. #CUA23
Don't miss our next event on May 10th with recently matched residents speaking on their experience with CARMS this year!
Sign up here: https://t.co/srLo5xJbxt
#uromed#meded#MedTwitter#CARMS#urology#Match2023